BDBM494851 3,4,5-Trichlorophenyl 3-deoxy-3-[4-(1,3,4-thiadiazol-2-yl)-1H-1,2,3-triazol-1-yl]-1-thio-α-D-galactopyranoside::US10988502, Example 19

SMILES OCC1O[C@H](Sc2cc(Cl)c(Cl)c(Cl)c2)C(O)[C@H]([C@H]1O)n1cc(nn1)-c1nncs1

InChI Key InChIKey=SRKDCCXTCUVMEY-UHFFFAOYSA-N

Data  2 Kd

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 494851   

TargetGalectin-1(Human)
Galecto Biotech

US Patent
LigandPNGBDBM494851(US10988502, Example 19 | 3,4,5-Trichlorophenyl 3-d...)
Affinity DataKd:  350nMAssay Description:Compounds for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the interaction between gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
Go to US Patent

TargetGalectin-3(Human)
Galecto Biotech

US Patent
LigandPNGBDBM494851(US10988502, Example 19 | 3,4,5-Trichlorophenyl 3-d...)
Affinity DataKd:  4.40E+3nMAssay Description:Compounds for galectins were determined by a fluorescence anisotropy assay where the compound was used as an inhibitor of the interaction between gal...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/1/2021
Entry Details
Go to US Patent